Search

everythinglearnresearchcommunity

for

Search:↓

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

A woman's mature cystic teratoma caused her virilization by producing testosterone.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

Treatments for hair loss vary, but cell-based options may be the future.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Trichoscopy is a useful non-invasive method for diagnosing different hair loss conditions.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

The three estrogen receptor genes are highly expressed in zebrafish neuromasts during development.